摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methylbutan-2-yl formate | 66794-46-5

中文名称
——
中文别名
——
英文名称
3-Methylbutan-2-yl formate
英文别名
——
3-Methylbutan-2-yl formate化学式
CAS
66794-46-5
化学式
C6H12O2
mdl
——
分子量
116.16
InChiKey
XEQSPMCNFJQDHU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] HETEROCYCLIC COMPOUND AND USE THEREOF<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE ET SON UTILISATION
    申请人:TAKEDA PHARMACEUTICALS CO
    公开号:WO2019027058A1
    公开(公告)日:2019-02-07
    The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I) : wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis treatment of narcolepsy.
    本发明提供了一种具有促进睡觉素2型受体激动剂活性的杂环化合物。公式(I)所代表的化合物:其中每个符号如规范中所述,或其盐,可用作预防治疗嗜睡症的药剂。
  • Nitrogen-containing aromatic derivatives
    申请人:——
    公开号:US20040053908A1
    公开(公告)日:2004-03-18
    Compounds represented by the following general formula: 1 [wherein A g is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X g is —O—, —S—, etc.; Y g is an optionally substituted C 6 - 14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T g1 is a group represented by the following general formula: 2 (wherein E g is a single bond or —N(R g2 )—, R g1 and R g2 each independently represent a hydrogen atom, an optionally substituted C 1-6 alkyl group, etc. and Z g represents a C 1-8 alkyl group, a C 3-8 alicyclic hydrocarbon group, a C 6-14 aryl group, etc.)], salts thereof or hydrates of the foregoing.
    由以下一般式表示的化合物: 1 [其中 A g 是可选择地取代的5-至14-成员杂环基团,等等;X g 是—O—,—S—,等等;Y g 是可选择地取代的C 6 - 14 芳基团,可选择地取代的5-至14-成员杂环基团,等等;以及 T g1 是由以下一般式表示的基团: 2 [其中 E g 是单键或—N(R g2 )—,R g1 和R g2 各自独立地表示氢原子,可选择地取代的C 1-6 烷基基团,等等,Z g 表示C 1-8 烷基基团,C 3-8 脂环烃基团,C 6-14 芳基团,等等], 其盐或上述化合物的水合物。
  • [EN] PYRAZOLONE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATOR<br/>[FR] COMPOSES DE PYRAZOLONE ET ACTIVATEUR DU RECEPTEUR DE LA THROMBOPOIETINE
    申请人:NISSAN CHEMICAL IND LTD
    公开号:WO2004033433A1
    公开(公告)日:2004-04-22
    A preventive, therapeutic or improving agent for diseases against which activation of the thrombopoietin receptor is effective or a platelet increasing agent, which contains a thrombopoietin receptor activator represented by the formula (1): wherein A is a C?2-14#191 aryl group, B is a hydrogen atom, a C?1-6#191 alkyl group, a C?1-3#191 alkyl group substituted with one or more fluorine atoms or a C?2-14#191 aryl group, D is a hydrogen atom, a C?1-6#191 alkyl group, a C?1-3#191 alkyl group substituted with one or more fluorine atoms or a C?2-14#191 aryl group, and E is a C?2-14#191 aryl group, a tautomer, prodrug or pharmaceutically acceptable salt of the activator or a solvate thereof, as an active ingredient.
    一种预防、治疗或改善针对血小板生成素受体激活有效的疾病的药剂或增加血小板的药剂,其中包含由式(1)表示的血小板生成素受体激活剂:其中A是C?2-14#191芳基,B是氢原子,C?1-6#191烷基,一个或多个氟原子取代的C?1-3#191烷基或C?2-14#191芳基,D是氢原子,C?1-6#191烷基,一个或多个氟原子取代的C?1-3#191烷基或C?2-14#191芳基,E是C?2-14#191芳基,激活剂的互变异构体、前药或药用可接受的盐或其溶剂,作为活性成分。
  • Acid- and radical-generating agent and method for generating acid and radical
    申请人:FUJIFILM Wako Pure Chemical Corporation
    公开号:US10451967B2
    公开(公告)日:2019-10-22
    It is a subject of the present invention to provide an acid- and radical-generating agent which has high sensitivity to an active energy ray having a wavelength of around 300 to 450 nm, and can exert both high acid-generating performance and high radical-generating performance, and has heat resistance; and a method for generating an acid and a radical. The present invention relates to a compound represented by the general formula (A); an acid- and radical-generating agent comprising the compound; and a method for generating an acid and a radical: wherein n pieces of R1 each independently represent an alkyl group, which may have a specific functional group in the chain, or in which a hydrogen atom may be substituted by a halogen atom; an alkoxy group, in which a hydrogen atom may be substituted by a halogen atom; an aryl group or an aryloxy group, in which a hydrogen atom may be substituted by a halogen atom, an alkyl group or a haloalkyl group; or an arylalkyl group or an arylalkyloxy group, in which a hydrogen atom may be substituted by a halogen atom, an alkyl group or a haloalkyl group; n pieces of R2 and R3 each independently represent a hydrogen atom, an alkyl group or an alkoxycarbonyl group; R4 to R7 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an alkenyl group, an aryl group, an alkoxycarbonyl group, a dialkylamino group or a nitro group; Y represents an oxygen atom, a sulfur atom, or a carbonyl group; n pieces of Z each independently represent a sulfonyl group or an alkoxyphosphoryl group; n represents 1 or 2.
    本发明的一个目的是提供一种对波长约为300至450纳米的活性能量射线具有高灵敏度的酸和自由基生成剂,能够发挥高酸生成性能和高自由基生成性能,并具有耐热性;以及一种生成酸和自由基的方法。本发明涉及一种由通式(A)表示的化合物;包括该化合物的酸和自由基生成剂;以及生成酸和自由基的方法:其中n个R1分别独立表示一种烷基基团,该烷基基团可能在链中具有特定的功能基团,或者氢原子可能被卤原子取代;一种烷氧基团,其中氢原子可能被卤原子取代;一种芳基或芳氧基,其中氢原子可能被卤原子,烷基或卤代烷基取代;或一种芳基烷基或芳基氧基,其中氢原子可能被卤原子,烷基或卤代烷基取代;n个R2和R3分别独立表示氢原子,烷基基团或烷氧羰基团;R4到R7分别独立表示氢原子,卤原子,烷基基团,烷氧基团,烯基基团,芳基,烷氧羰基团,二烷基氨基团或硝基;Y表示氧原子,硫原子或羰基;n个Z分别独立表示磺酰基或烷氧基磷酰基;n表示1或2。
  • Method for producing anellated tetrahydro-{1h}-triazoles
    申请人:——
    公开号:US20040097728A1
    公开(公告)日:2004-05-20
    The present invention relates to a process for preparing fused tetrahydro-[ 1 H]-triazoles of the formula I 1 where the variables R a , Z, Z 1 , X, W, n and Q are as defined in claim 1, by cyclization of compounds of the formula II 2 where R is C(X)OR 2 or C(X)SR 2 , where X is oxygen or sulfur, and R 2 is as defined in claim 1, in the presence of a base. The invention also relates to compounds of the formula I where W is sulfur if Z is a methylene group optionally substituted by R a , and furthermore to compounds of the formula I where Q is a benzoxazole or benzothiazole radical, and to the use of these compounds as herbicides.
    本发明涉及一种制备公式I的熔融四氢咪唑的方法,其中变量Ra、Z、Z1、X、W、n和Q如权利要求1中定义,通过在碱存在下,将公式II的化合物环化得到,其中R为C(X)OR2或C(X)SR2,其中X为氧或硫,R2如权利要求1中定义。该发明还涉及公式I的化合物,其中如果Z是可选地由Ra取代的亚甲基基团,则W为硫,此外还涉及公式I的化合物,其中Q为苯并噁唑或苯并噻唑基团,并将这些化合物用作除草剂。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物